ARMK delivered its August 11 earnings print and the market responded emphatically — the stock jumped 8.5% on the day and closed the week at $60.47, a complete reversal of the defensive setup that preceded the report.
The post-earnings reaction unwound everything that had made the pre-print setup look cautious. Options traders had pushed the put/call ratio to 0.985 ahead of results; it has since climbed further to 1.04, running nearly two standard deviations above its 20-day average of 0.81. That reading is notable in context — the hedges were placed before results and the ratio has stayed elevated even after the stock's move, suggesting some residual caution rather than outright relief. Short sellers moved the other way. Short interest dropped 8.4% in a single session on August 11, falling to 3.6% of the free float — down about 7% across the week and 7% over the past month. The borrow market tells the same story: availability remains extraordinarily loose at over 5,000% of short interest, and cost to borrow is a negligible 0.43% annually. There is no meaningful squeeze dynamic here — short interest was never large enough, and the covering this week looks like routine post-earnings cleanup rather than forced exits.
The Street moved quickly to re-rate the stock. Multiple firms raised targets on August 12, the morning after results, with the moves uniformly upward and no downgrades in sight. Stifel lifted its target from $54 to $70 while holding its Buy rating — the most dramatic move in the group. Jefferies similarly raised from $62 to $70, and UBS moved from $67 to $71. Baird went to $69 from $63. Those four actions alone, all on the same morning, set the tone: the analyst consensus has become decisively more constructive. The mean price target now sits at $65.31, which at first glance looks below the current $60.47 price — but the pre-results targets in that average were set when the stock was trading near $56, and the post-results raises are pulling that average up in real time. The forward earnings picture has been revised sharply higher; the 12-month forward EPS growth factor scores in the 96th percentile, and EPS momentum over both 30- and 90-day horizons remains positive. The bull case centres on cost discipline, data centre contract growth, and strong customer retention. The bear case focuses on leverage, wage inflation, and the sustainability of margin gains in a slower macro environment — risks that have not disappeared, but that the earnings print apparently did enough to address for now.
On valuation, the re-rating is visible across the multiples. The P/E has moved to 23.6x, up about 1.6 turns on the day alone and just over a turn in the week. EV/EBITDA has risen to 12.6x, up roughly 0.6 turns this week. Neither multiple is extreme, but the moves reflect a market that has meaningfully re-priced growth expectations overnight. The ORTEX short score dipped to 36.0 from 37.1 over the week — the score has been grinding slowly lower for months, consistent with a stock where short conviction is minimal and fading.
Among correlated peers, the week's moves were mixed. WEN on Nasdaq fell 1.8% over the week while VIK on the NYSE dropped 5.6%, making ARMK's 7.6% weekly gain stand out clearly against its closest-correlated names. That divergence points to company-specific drivers — the earnings beat — rather than a broader sector lift.
The next scheduled earnings event is November 17. Between now and then, the question is whether the analyst target upgrades that have already happened pull the stock further toward the $70 consensus that several firms have now adopted, or whether the elevated put/call ratio signals that some investors are already looking for an exit after the run.
See the live data behind this article on ORTEX.
Open ARMK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
